This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Imatinib - Indications, Dosage, Side Effects and Precautions — Description, Dosage, Side Effects | PillsCard
OTC
Imatinib - Indications, Dosage, Side Effects and Precautions
INN: imatinib
Data updated: 2026-04-18
Available in:
🇩🇪🇬🇧🇯🇵🇵🇹
Form
—
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Novartis Europharm Ltd
ATC Code
L01EA01
Source
EMA · EMEA/H/C/002551
This medication is a protein-tyrosine kinase inhibitor, prescribed for treating certain type of cancers such as chronic myelogenous leukemia (cancer of the white blood cells, acute lymphoblastic leukemia(cancer of the white blood cells), gastrointestinal stromal tumors (tumors of the gastrointestinal tract and other cancers. It prevents the growth of cancer cells.
⚠️ Warnings
•Caution should be exercised in patients with history of high blood pressure, heart attack, irregular heartbeat, diabetes, heart, lung, thyroid or liver disease, smokers, street drug and heavy alcohol users.
Avoid excess dosage.
It may cause diarrhea during the treatment. Consult with your doctor if it does so.
Consult with your doctor during pregnancy and breastfeeding.